Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Upsala Journal of Medical Sciences|October 12, 2020
Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinomaBengt Tholander, Anthoula Koliadi, Johan Botling, et al.
BMC Genomics|March 19, 2013
Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencingXiang Jiao, Sean D Hooper, Tatjana Djureinovic, et al.
Molecular & Cellular Proteomics : MCP|February 26, 2013
Parallel visualization of multiple protein complexes in individual cells in tumor tissueKarl-Johan Leuchowius, Carl-Magnus Clausson, Karin Grannas, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
c-MET as a biomarker in patients with surgically resected non-small cell lung cancerGeorgios Tsakonas, Johan Botling, Patrick Micke, et al.
Cancers|July 2, 2021
Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 BlockadeMohamed Eltahir, Johan Isaksson, Johanna Sofia Margareta Mattsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2012
Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumorsKarolina Edlund, Ola Larsson, Adam Ameur, et al.
Journal of Neuroendocrinology|May 5, 2025
The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective studyKazhan Mollazadegan, Johan Botling, Britt Skogseid, et al.
Acta Oncologica (Stockholm, Sweden)|March 28, 2015
LRIG1 is a prognostic biomarker in non-small cell lung cancerSamuel Kvarnbrink, Terese Karlsson, Karolina Edlund, et al.
International Journal of Cancer|October 2, 2012
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinomaJohan Staaf, Sofi Isaksson, Anna Karlsson, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 9, 2015
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung CarcinomaLena Tran, Johanna S M Mattsson, Björn Nodin, et al.
Pageof 13